KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹9.32 Cr | ₹7.87 Cr | ₹7.08 Cr | ₹6.27 Cr | ₹4.99 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KOPRAN ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹9.32 Cr |
| Mar2024 | ₹7.87 Cr |
| Mar2023 | ₹7.08 Cr |
| Mar2022 | ₹6.27 Cr |
| Mar2021 | ₹4.99 Cr |
How is Deferred Tax Assets / Liabilities of KOPRAN Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.32 Cr | 18.45 | |
| Mar2024 | ₹7.87 Cr | 11.15 | |
| Mar2023 | ₹7.08 Cr | 12.87 | |
| Mar2022 | ₹6.27 Cr | 25.74 | |
| Mar2021 | ₹4.99 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹960.7 Cr | -2.3% | 0.4% | 10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.3% |
0.4% |
10.9% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses